Delivery Order SPE2DB22D1103-SPE2DB23FE6AP
Award Date 9/20/23
Potential Completion Date 9/21/23
Potential Value $141
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,604.65 delivery order to AmerisourceBergen Drug Corp for the supply of Bepotastine 1.5% eye drops (10mL) on September 11, 2025, with completion scheduled for September 12, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Bepotastine 1.5% eye drops. The $1,270.95 firm fixed-price contract has a completion date of June 25, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Olopatadine HCL 0.1% eye drops (5 mL units) with a ceiling value of $1,148.94. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The pharmaceutical products will be...
- The Defense Logistics Agency awarded a $266,640 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the refreshment of 30 units of Optive Advanced eye drops. The single day contract has a period of performance from September 18-19, 2023 for product delivery. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania to support the DLA's medical supply needs. No major subcontractors or set aside designations were identified. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,261.74 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $14,900 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Brimomidine 0.2% eye drops. Under this contract, Amerisourcebergen will deliver 5mL bottles of the eye drops to a location in Conshohocken, Pennsylvania by September 22, 2023. As a major provider of medical supplies and pharmaceuticals, Amerisourcebergen routinely supports the Defense Logistics Agency's mission to provide critical resources to military treatment facilities...
- The Defense Logistics Agency awarded a delivery order valued at $2,730.44 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as the...
- The Defense Logistics Agency awarded a $17,250 firm fixed price delivery order to Amerisourcebergen Drug Corporation for eye itch relief drops. As the prime contractor, Amerisourcebergen will supply 4561425622 brand 0.025% eye drops in 5mL bottles to the Defense Logistics Agency from its facility in Conshohocken, Pennsylvania. The delivery order was issued on July 7, 2023 under an existing DLA contract vehicle and is to be completed by July 10, 2023. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a $201,760 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Olopatadine hydrochloride 0.1% eye drops. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the eye drops to meet requirements under the Defense Logistics Agency's pharmaceutical supply chain contracts. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in July 2023. No set aside designation or...
- The Defense Logistics Agency awarded a $140,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Olopatadine hydrochloride 0.1% eye drops. To be performed in Conshohocken, Pennsylvania from September 20-21, 2023, this order is issued against an existing DLA pharmaceuticals contract vehicle. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, DLA supports military treatment facilities worldwide in their delivery of healthcare...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB23FE6APDelivery Order
The Defense Logistics Agency awarded a $141,400 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Bepotastine 1.5% eye drops. Under this contract, Amerisourcebergen will provide approximately 5 milliliters of the ophthalmic solution to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in September 2023. No subcontractors or set aside designations were identified. This delivery order was issued against an existing DLA pharmaceuticals contract vehicle to fulfill requirements for topical ocular medications.
Generated 12/20/23, 9:07 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $141 | 9/20/23 |